↓ Skip to main content

Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway

Overview of attention for article published in Frontiers in Pharmacology, May 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vitamin D3 alleviates nonalcoholic fatty liver disease in rats by inhibiting hepatic oxidative stress and inflammation via the SREBP-1-c/ PPARα-NF-κB/IR-S2 signaling pathway
Published in
Frontiers in Pharmacology, May 2023
DOI 10.3389/fphar.2023.1164512
Pubmed ID
Authors

Doha Reda, Gehad E. Elshopakey, Talat A. Albukhari, Samah J. Almehmadi, Bassem Refaat, Engy F. Risha, Hebatallah A. Mahgoub, Mohamed E. El-Boshy, Fatma M. Abdelhamid

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 19%
Student > Master 3 19%
Other 1 6%
Unknown 9 56%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 2 13%
Agricultural and Biological Sciences 2 13%
Medicine and Dentistry 1 6%
Engineering 1 6%
Unknown 10 63%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 May 2024.
All research outputs
#17,694,259
of 25,939,391 outputs
Outputs from Frontiers in Pharmacology
#7,839
of 20,058 outputs
Outputs of similar age
#232,144
of 398,542 outputs
Outputs of similar age from Frontiers in Pharmacology
#240
of 816 outputs
Altmetric has tracked 25,939,391 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,058 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 398,542 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 816 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.